Gender differences in the adverse events’ profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis
Delia Colombo,1 Emanuela Zagni,1 Mihaela Nica,1 Sara Rizzoli,2 Alessandra Ori,2 Gilberto Bellia1 1Patient Access, Novartis Farma S.p.A., Origgio, Varese, 2MediNeos Observational Research, Modena, Italy Background: MetaGeM is a wide gender-medicine project comprising post hoc and meta-analyses by g...
Main Authors: | Colombo D, Zagni E, Nica M, Rizzoli S, Ori A, Bellia G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/gender-differences-in-the-adverse-eventsrsquo-profile-registered-in-se-peer-reviewed-article-DDDT |
Similar Items
-
A gender-medicine post hoc analysis (MetaGeM) project to test sex differences in previous observational studies in different diseases: methodology
by: Colombo D, et al.
Published: (2014-10-01) -
Adverse effects of psychotherapy: protocol for a systematic review and meta-analysis
by: Rahel Klatte, et al.
Published: (2018-09-01) -
The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis
by: Hou H, et al.
Published: (2019-05-01) -
Adverse Childhood Experiences and Early Pubertal Timing Among Girls: A Meta-Analysis
by: Lei Zhang, et al.
Published: (2019-08-01) -
Reporter’s occupation and source of adverse device event reports contained in the FDA’s MAUDE database
by: Kavanagh KT, et al.
Published: (2019-07-01)